Pear’s new financial disclosures provided more insight into how the company derives revenue from its digital therapeutics. In the first quarter, Pear filled a total of 9,200 prescriptions, about 57% ...
The most common and easiest way to take medicine is by swallowing a pill. For a new class of therapies, dosing is even easier—just a few finger taps on a touchscreen. The now-defunct Pear Therapeutics ...
Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system. In recent ...
Pear Therapeutics Inc. released nine-month, real-world data showing long-term reduction in costly health care utilization categories, including inpatient stays and emergency department visits, in ...
Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022 Interim results from the DREAM trial showed ...
Alcohol is the most common substance use disorder (SUD), representing 70% of the more than 40 million people with SUD1 The real-world observational study evaluated 548 patients with alcohol-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results